Dr Rosalind Watts

As Clinical Lead of the Psilocybin for Depression Study at Imperial College London, Dr Rosalind Watts led the clinical team which facilitated over a hundred psilocybin treatment sessions in 2019.  During her 5 years at the Imperial College Centre for Psychedelic Research, Dr Watts published qualitative research into the psychological mechanisms of psilocybin treatment, and a model of psychedelic therapy, ‘Accept, Connect, Embody (ACE)’.  In her new role as Clinical Director of Synthesis Institute Dr Watts is building a new therapeutic programme for people with depression to access legal psychedelic therapy in the Netherlands.  This new treatment model combines therapeutic psychedelic retreats with a